Endophilin A2, the sole endophilin A family member expressed in hematopoietic cells, regulates various aspects of membrane dynamics, including autophagy and endocytosis. Recent studies in rodents highlight the essential role of endophilin A2 in modulating immune responses. Here we report a homozygous frameshift variant in the SH3GL1 gene (NM_003025.3:c.427delC; p.Leu143Serfs*9), detected by whole-exome sequencing in a 14-year-old boy with predominantly antibody deficiency. The patient, who is issued from a consanguineous Lebanese family, has presented since the age of 18 months with recurrent respiratory tract infections, low peripheral B cell counts, and pan-hypogammaglobulinemia, with no history of opportunistic infections. This defect is associated with decrease in switched memory B cells development, impaired in vitro B cell proliferation, and diminished in vitro IgG production. The detected variant in SH3GL1 segregates with the disease in the family and abolishes the expression of the protein in the patient’s peripheral blood. Interestingly, endophilin A2–deficient Sh3gl1-/- mice have been reported to present defects in germinal center B cell responses and in the production of high-affinity IgG. Our data suggest that endophilin A2 deficiency impairs antibody production in humans. Reporting further cases with mutations in SH3GL1 is needed to better characterize the inborn error of immunity linked to this gene.
Reference
